The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Part of paid clinical trials in San Diego, California.

Sponsor
Invivoscribe, Inc.
Study ID
NCT06222164
Status
Recruiting
Apply to this trial

Conditions

  • Hematologic Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Key Dates

Start date
Mar 30, 2024
Status verified
May 2025
Primary completion
Mar 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Residual Specimens
    Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing.

Primary Outcome Measure

Enrollment [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
LabPMMSan DiegoCalifornia92121
Andrew Schut
[email protected]
858-224-6600
Jordan Thornes (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Diego, CA

By research site
LabPMM· San Diego, CA

Related Studies